BioSyent Inc.
RX.V
TSX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -9.76% | 40.27% | -31.90% | 46.51% | -11.97% |
| Total Depreciation and Amortization | -24.11% | -57.30% | 317.60% | -9.33% | 4.34% |
| Total Amortization of Deferred Charges | 1,290.63% | 357.14% | -85.71% | -- | -- |
| Total Other Non-Cash Items | -224.20% | -92.62% | 461.90% | 2.00% | 63.35% |
| Change in Net Operating Assets | 140.17% | -778.74% | -89.24% | 236.40% | -336.00% |
| Cash from Operations | 601.16% | -126.77% | -61.36% | 538.44% | -255.73% |
| Capital Expenditure | 2.88% | 40.34% | -223.61% | -20.00% | -160.87% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -82.05% | -40.32% | 134.85% | -170.38% | 2,360.31% |
| Cash from Investing | -83.51% | 19.34% | 117.08% | -170.60% | 2,384.28% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -1.05% | -1.93% | -1.30% | -0.88% | -1.33% |
| Issuance of Common Stock | -89.23% | -63.93% | 223.11% | 32.11% | -- |
| Repurchase of Common Stock | 97.54% | 74.78% | -16,515.79% | 93.83% | 76.56% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -3.62% | -7.12% | 4.16% | -0.37% | 2.01% |
| Other Financing Activities | 3.82% | 6.43% | 4.11% | 2.67% | 3.85% |
| Cash from Financing | 56.31% | 64.68% | -637.69% | 39.06% | 58.36% |
| Foreign Exchange rate Adjustments | -900.00% | -102.24% | 217.99% | -9,550.00% | 100.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 367.90% | -69.34% | -166.27% | -79.19% | 606.51% |